Navigation Links
Renhuang Pharmaceuticals Exhibits All-Natural Products at the 63rd PHARMACHINA Fair
Date:5/13/2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... Transparency Market Research, in its report titled ... by Application - Cancer, Metabolic, CVS, CNS & others, ... - Global Industry Analysis, Size, Share, Growth, Trends and ... therapeutics market was worth US$14.1 billion in 2011 and ... an 8.7% CAGR. , The two main types of ...
(Date:9/29/2014)... METTLER TOLEDO’s new line of XPE ... precision balances as well as automated dosing ... can carry out their daily weighing tasks worry free, ... deliver consistently reliable and compliant results, thanks to new ... of the biggest challenges in analytical and micro-analytical weighing ...
(Date:9/29/2014)... ANGELES , Sept. 29, 2014 ... biopharmaceutical research and development company specializing in oncology, ... Administration (FDA) has granted multiple Orphan Drug Designations ... three indications: glioblastoma multiforme (GBM), small cell lung ... version of the widely-used chemotherapeutic agent, doxorubicin. ...
(Date:9/27/2014)... in the peer-reviewed Journal of Animal Science ... crops has no impact on the health or productivity ... literature and field data sets, the article documents evidence ... GE crops are comparable with those of animals fed ... GE feed crops have become an increasing component of ...
Breaking Biology Technology:Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 2Global Peptide Therapeutics Market to be Worth US$25.4 Billion by 2018: Transparency Market Research 3New Line of XPE Balances from METLER TOLEDO is Designed for High Performance and Ease of Compliance 2CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer 2CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer 3CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer 4CytRx Receives Multiple FDA Orphan Drug Designations for Aldoxorubicin for the Treatment of Glioblastoma, Small Cell Lung Cancer and Ovarian Cancer 5
... Calif., May 6 Finesse Solutions, LLC,Santa ... control solutions for,life sciences process applications, announced ... of Software. Basil brings over 19 years ... a focus on,implementing high efficiency engineering, resource ...
... Award at Leading Venture Contest Makes Carnegie Mellon ,Winningest, ... ... time, a team of,students from the Tepper School of Business at Carnegie ... competition Moot,Corp(R). This year,s winning venture business -- NeuroBank -- has developed,a ...
... Md., May 6 PharmAthene, Inc.,(Amex: PIP ) ... threats, announced today that its financial results,for the first ... 13, 2008., PharmAthene management will be hosting a ... The call is scheduled to begin at,4:30 p.m. Eastern ...
Cached Biology Technology:Basil Zimmo Joins Finesse Solutions as Vice-President of Software 2Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition 2PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008 2
(Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 populations ... the globe dropped 52 percent, says the 2014 ... Fund (WWF). This biodiversity loss occurs disproportionately in ... of high-income countries. , In addition to the ... point to other warning signs about the overall ...
(Date:9/29/2014)... Texas at Arlington research team says recently identified radiation ... lab could open doors for homeland security and medical ... the Oct. 1 issue of Optics Letters , ... describe a new method to fabricate transparent nanoscintillators by ... a transparent ceramic is formed. A scintillator refers ...
(Date:9/29/2014)... received a five-year, $6 million grant for clinical ... and development of safe and effective treatments for ... the National Institutes of Health, National Institute on ... Medication Development for Cocaine Use Disorder to oversee ... decisions on moving forward with more expensive large-scale ...
Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3New VCU center to target cocaine addiction 2
... of a tiny shrimp-like species, known scientifically as ... non-native quagga mussels in the Great Lakes, say NOAA ... Diporeia and many aquatic species have steadily ... NOAA,s Great Lakes Environmental Laboratory published,this week in ...
... University have developed a new tool that makes it possible ... generation of blood vessels. The researchers, findings, published in ... enable scientists to determine what signals in the body attract ... tumor research. The new invention is a tiny cell ...
... a startling result, a new study published by the ... than 80 percent of the world,s major armed conflicts ... biologically diverse and threatened places on Earth. Titled ... conservation scientists compared major conflict zones with the Earth,s ...
Cached Biology News:Tiny tool to control growing blood vessels opens new potential in tumor research 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3